Results 261 to 270 of about 155,675 (375)

An Immunological Assessment of B and T Cells in Patients with Chronic Graft Vs Host Disease Undergoing Extracorporal Photopheresis (ECP) [PDF]

, 2012
Jignesh Dalal, Hamid Ashraf, Thomas M. Yankee, Joseph P. McGuirk, Sunil Abhyankar   +4 more
openalex   +1 more source

Are we ignoring sex differences in haematological malignancies? A call for improved reporting

British Journal of Haematology, EarlyView.
A large body of data indicates that there are sex differences in the incidence of haematological malignancies, their clinical presentation and molecular profiles, and possibly also their aetiologies. Furthermore, sex‐related differences exist in treatment tolerability and outcomes.
Ora Paltiel, Sumita Ratnasingam, Hui‐Peng Lee   +2 more
wiley   +1 more source

PIN16 COST-EFFECTIVENESS OF POSACONAZOLE VS. FLUCONAZOLE IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE IN CANADA

, 2008
Amir Abbas Tahami Monfared, AK O’Sullivan, George Papadopoulos   +2 more
openalex   +1 more source

Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease [PDF]

, 2013
Masayuki Fujino, Xiao‐Kang Li
openalex   +1 more source

How low can we go? Comparison of liberal and restrictive red cell transfusion thresholds in paediatric allogeneic haematopoietic stem cell transplantation: A randomized multicentre feasibility trial

British Journal of Haematology, EarlyView.
Optimal red blood cell transfusion thresholds for children with bone marrow failure are uncertain. Children may be able to safely tolerate lower haemoglobin thresholds, thereby reducing transfusions, which have risks. This study in paediatric allogeneic haematopoietic stem cell transplant aimed to assess feasibility of recruitment and protocol ...
H. V. New, E. Sanderson, V. Hopkins, H. Thomas, A. Gassas, M. Adams, B. Gibson, K. Patrick, R. Wynn, L. Hoole, H. Smethurst, M. Lobo‐Clarke, L. Smith, A. Mora, S. J. Stanworth   +14 more
wiley   +1 more source

Autologous Gastrointestinal Graft-vs-Host Disease in a Patient With Multiple Myeloma and Hematopoietic Stem Cell Transplantation. [PDF]

ACG Case Rep J
Raza H, Naffouj S, Guzman G, Shuja A.
europepmc   +1 more source

Graft-vs-Host Disease After Liver Transplantation: A Diagnostic and Management Challenge. [PDF]

ACG Case Rep J, 2020
Chin JY, Gong J, Gane E.
europepmc   +1 more source

Biomarkers of graft-vs-host disease: Understanding and applications for the future. [PDF]

World J Transplant, 2021
Nagasawa M.
europepmc   +1 more source

Soluble Aminopeptidase N (CD13) Is a Diagnostic Biomarker of Late-Onset Chronic Graft Vs. Host Disease in Adults [PDF]

, 2013
Sabine Ivison, Amina Kariminia, Barry E. Storer, Robert McMaster, John A. Hansen, Stephanie J. Lee, Kirk R. Schultz   +6 more
openalex   +1 more source

The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low‐ and middle‐income countries

British Journal of Haematology, EarlyView.
Globally, sickle cell disease (SCD) is the most common inherited haemoglobinopathy. The highest burden of SCD is encountered in low‐ and middle‐income countries (LMICs), most of which lack the resources to contend with the disease. Blood transfusion remains central to the emergent treatment and prevention of complications of SCD.
Jeremy W. Jacobs, Luiz Amorim, France Pirenne, Claude Tayou, Ijele Adimora, Lydia H. Pecker, Aaron A. R. Tobian, Jeannie Callum, Julie Makani, Mark T. Gladwin, Meghan Delaney, Darrell J. Triulzi, Isaac Odame, Evan M. Bloch   +13 more
wiley   +1 more source